Journal Article Page
Jump to
European Urology
Volume 58, issue 2, pages e19-e28, August 2010Case Study of the Month
Neoadjuvant Temsirolimus Effectiveness in Downstaging Advanced Non–Clear Cell Renal Cell Carcinoma
00223-X/assets/eulogo1.jpg)
Accepted 3 March 2010, Published online 12 March 2010, pages 307 - 310
Abstract Full Text Full-Text PDF (406 KB) Create Platinum Slide Series
Abstract
A 35-year-old woman presented with a 12-cm right renal mass with retroperitoneal lymph node involvement and pulmonary and bone metastases. Renal mass biopsy revealed an unclassified high-grade non–clear cell renal cell carcinoma (RCC) with eosinophilic cells. Due to the extent of the disease, neoadjuvant temsirolimus was initiated. After 6 wk of treatment, a significant downstaging of the disease and complete disappearance of the metastases were noticed on computed tomography scan. Three months later, a laparoscopic radical nephrectomy and lymphadenectomy was performed. Final pathology confirmed a high-grade non–clear cell RCC, with necrotic changes on lymph node specimens, pT1bN0Mx.
Keywords: Temsirolimus, Non–clear cell renal cell carcinoma, Neoadjuvant.
Article information
PII: S0302-2838(10)00223-X
DOI: 10.1016/j.eururo.2010.03.005
© 2010 European Association of Urology, Published by Elsevier B.V.
Recommend this article
Currently this article has a rating of 0. Please log in to recommend it.
Copyright © 